Genomics of COVID-19: molecular mechanisms going from susceptibility to severity of the disease

The current COVID-19 pandemic (https://www.who. int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19%2D%2 D-11-march-2020) has highlighted the importance of science and medicine, specifically public health, in our modern societies. Countries have taken different approaches to the pandemic. Science and medicine will play an important role in our way forward. Specifically, genetics and genomics will be central in discovering variations in virus strains and their impact on patients’ susceptibility, progression, and outcome. Additionally, the human and zoonotic hosts’ ability to fend off the virus and the severity of disease in patients will have genomic elements. Furthermore, the question of long-term immunity to COVID-19 will likely have a genomic basis which should be investigated. Some of these genetic and genomic investigations will undoubtedly be suitable for publication in Human Genomics. We, therefore, expressly welcome submissions of manuscripts on such subjects to the thematic series on the “Genomics of COVID-19: molecular mechanisms going from susceptibility to severity of the disease.” As citizen-scientists, we also have a responsibility toward society as citizens first and foremost but also specifically as scientists working on improving the lives of all humans. Political aspects of the COVID-19 pandemic and its origins can and should not be ignored as the needs of all humans: rich and poor, various ethnicities, rural vs. urban, different health and political systems, etc. These aspects, if fitting within the scope of the journal, will also be considered for publication in this thematic series in Human Genomi